The humoral response and antibodies against SARS-CoV-2 infection

Nat Immunol. 2022 Jul;23(7):1008-1020. doi: 10.1038/s41590-022-01248-5. Epub 2022 Jun 27.

Abstract

Two and a half years into the COVID-19 pandemic, we have gained many insights into the human antibody response to the causative SARS-CoV-2 virus. In this Review, we summarize key observations of humoral immune responses in people with COVID-19, discuss key features of infection- and vaccine-induced neutralizing antibodies, and consider vaccine designs for inducing antibodies that are broadly protective against different variants of the SARS-CoV-2 virus.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19*
  • Humans
  • Immunity, Humoral
  • Pandemics
  • SARS-CoV-2
  • Viral Vaccines*

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Viral Vaccines